Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma

Clinical trial NCT01754402 · UNKNOWN

Trial details

NCT number: NCT01754402
Sponsor: Cristina Gasparetto
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2013-01-07
Primary completion: 2016-12-06
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.